AEA Investors-backed Verdesian completed the acquisition of Cytozyme.

AEA Investors-backed Verdesian, a developer of fertilizers and agrochemicals, completed the acquisition of Cytozyme, a biosimulator manufacturer. Financial terms were not disclosed. “For more than four decades, Cytozyme’s mission has been to help farmers achieve sustainable yields through innovative solutions. We firmly believe that Verdesian Life Sciences has the technology, capabilities, and the people to continue that mission in a way that is true to our ideals. Our two companies’ product mixes are incredibly complementary; this is a great day for growers everywhere," Eric Baughman, Cytozyme CEO.